Literature DB >> 30358732

Physiologically assessed hot flashes and endothelial function among midlife women.

Rebecca C Thurston1,2, Yuefang Chang3, Emma Barinas-Mitchell2, J Richard Jennings1, Roland von Känel4, Doug P Landsittel5, Karen A Matthews1,2.   

Abstract

OBJECTIVE: Hot flashes are experienced by most midlife women. Emerging data indicate that they may be associated with endothelial dysfunction. No studies have tested whether hot flashes are associated with endothelial function using physiologic measures of hot flashes. We tested whether physiologically assessed hot flashes were associated with poorer endothelial function. We also considered whether age modified associations.
METHODS: Two hundred seventy-two nonsmoking women reporting either daily hot flashes or no hot flashes, aged 40 to 60 years, and free of clinical cardiovascular disease, underwent ambulatory physiologic hot flash and diary hot flash monitoring; a blood draw; and ultrasound measurement of brachial artery flow-mediated dilation to assess endothelial function. Associations between hot flashes and flow-mediated dilation were tested in linear regression models controlling for lumen diameter, demographics, cardiovascular disease risk factors, and estradiol.
RESULTS: In multivariable models incorporating cardiovascular disease risk factors, significant interactions by age (P < 0.05) indicated that among the younger tertile of women in the sample (age 40-53 years), the presence of hot flashes (beta [standard error] = -2.07 [0.79], P = 0.01), and more frequent physiologic hot flashes (for each hot flash: beta [standard error] = -0.10 [0.05], P = 0.03, multivariable) were associated with lower flow-mediated dilation. Associations were not accounted for by estradiol. Associations were not observed among the older women (age 54-60 years) or for self-reported hot flash frequency, severity, or bother. Among the younger women, hot flashes explained more variance in flow-mediated dilation than standard cardiovascular disease risk factors or estradiol.
CONCLUSIONS: Among younger midlife women, frequent hot flashes were associated with poorer endothelial function and may provide information about women's vascular status beyond cardiovascular disease risk factors and estradiol.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30358732     DOI: 10.1097/GME.0000000000001239

Source DB:  PubMed          Journal:  Menopause        ISSN: 1072-3714            Impact factor:   3.310


  8 in total

1.  The longitudinal relation of inflammation to incidence of vasomotor symptoms.

Authors:  Ellen B Gold; Guibo Xing; Nancy E Avis; Sioban Harlow; Hadine Joffe; Karen Matthews; Jelena M Pavlovic; Rebecca C Thurston; Elaine Waetjen
Journal:  Menopause       Date:  2022-08-01       Impact factor: 3.310

2.  Associations of hypertensive disorders of pregnancy and gestational diabetes mellitus with menopausal symptoms at midlife in Project Viva.

Authors:  Diana C Soria-Contreras; Wei Perng; Sheryl L Rifas-Shiman; Lidia Mínguez-Alarcón; Marie-France Hivert; Jan Shifren; Emily Oken; Jorge E Chavarro
Journal:  Menopause       Date:  2022-08-02       Impact factor: 3.310

3.  Cardiovascular health after menopause transition, pregnancy disorders, and other gynaecologic conditions: a consensus document from European cardiologists, gynaecologists, and endocrinologists.

Authors:  Angela H E M Maas; Giuseppe Rosano; Renata Cifkova; Alaide Chieffo; Dorenda van Dijken; Haitham Hamoda; Vijay Kunadian; Ellen Laan; Irene Lambrinoudaki; Kate Maclaran; Nick Panay; John C Stevenson; Mick van Trotsenburg; Peter Collins
Journal:  Eur Heart J       Date:  2021-03-07       Impact factor: 29.983

4.  Effects of Chlorogenic Acids on Menopausal Symptoms in Healthy Women: A Randomized, Placebo-Controlled, Double-Blind, Parallel-Group Trial.

Authors:  Yuka Enokuchi; Atsushi Suzuki; Tohru Yamaguchi; Ryuji Ochiai; Masakazu Terauchi; Kiyoshi Kataoka
Journal:  Nutrients       Date:  2020-12-07       Impact factor: 5.717

Review 5.  Coronary Artery Disease in Women: A Comprehensive Appraisal.

Authors:  Nili Schamroth Pravda; Orith Karny-Rahkovich; Arthur Shiyovich; Miri Schamroth Pravda; Naomi Rapeport; Hana Vaknin-Assa; Alon Eisen; Ran Kornowski; Avital Porter
Journal:  J Clin Med       Date:  2021-10-12       Impact factor: 4.964

Review 6.  Sex hormones and immune system: Menopausal hormone therapy in the context of COVID-19 pandemic.

Authors:  Marina Averyanova; Polina Vishnyakova; Svetlana Yureneva; Oksana Yakushevskaya; Timur Fatkhudinov; Andrey Elchaninov; Gennady Sukhikh
Journal:  Front Immunol       Date:  2022-08-02       Impact factor: 8.786

7.  High low-density lipoprotein cholesterol level is associated with an increased risk of incident early-onset vasomotor symptoms.

Authors:  Hye Rin Choi; Yoosoo Chang; Yejin Kim; Jeonggyu Kang; Min-Jung Kwon; Ria Kwon; Ga-Young Lim; Kye-Hyun Kim; Hoon Kim; Yun Soo Hong; Di Zhao; Juhee Cho; Eliseo Guallar; Hyun-Young Park; Seungho Ryu
Journal:  Sci Rep       Date:  2022-08-27       Impact factor: 4.996

8.  Hypertensive disorders of pregnancy and menopausal symptoms: a cross-sectional study from the data registry on experiences of aging, menopause, and sexuality.

Authors:  Stephanie S Faubion; Amanda King; Andrea G Kattah; Carol L Kuhle; Richa Sood; Juliana M Kling; Kristin C Mara; Ekta Kapoor
Journal:  Menopause       Date:  2020-08-17       Impact factor: 3.310

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.